Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)
HKD 1.16
(0.87%)
HKD 1.16
(0.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.15 Billion | 1.27 Billion | 1.16 Billion | 1.02 Billion | 950 Million | 948.93 Million |
| Cost of Revenue | 509.62 Million | 511 Million | 489.79 Million | 478.71 Million | 427.25 Million | 353.9 Million |
| Gross Profit | 641.51 Million | 766.67 Million | 675.36 Million | 545.55 Million | 522.75 Million | 595.02 Million |
| Operating Expenses | 210.13 Million | 347.75 Million | 255.62 Million | 226.88 Million | 220.87 Million | 248.8 Million |
| Selling, General and Administrative Expenses | 260.25 Million | 264.79 Million | 226.43 Million | 163.79 Million | 181.89 Million | 190.03 Million |
| Research and Development Expenses | 90.8 Million | 79.47 Million | 67.02 Million | 60.03 Million | 56.08 Million | 46.35 Million |
| Other Expenses | - | 445 Thousand | 111 Thousand | 716 Thousand | -68.96 Million | -57.39 Million |
| Cost and Expenses | 719.76 Million | 858.75 Million | 745.41 Million | 705.6 Million | 648.13 Million | 602.71 Million |
| Operating Income | 431.38 Million | 410.02 Million | 380.76 Million | 320.49 Million | 290.35 Million | 345.05 Million |
| Interest Expense | 989 Thousand | 371 Thousand | 641 Thousand | 4.82 Million | 5.3 Million | 1.15 Million |
| Income Tax Expense | 91.39 Million | 82.55 Million | 85.16 Million | 66.5 Million | 58.73 Million | 73.81 Million |
| Earnings before Tax | 414.05 Million | 438.4 Million | 439.32 Million | 331.29 Million | 314.09 Million | 377.77 Million |
| Net Income | 326 Million | 358.05 Million | 358.17 Million | 268.13 Million | 255.43 Million | 303.96 Million |
| Earnings Per Share Basic | 0.22 | 0.24 | 0.24 | 0.17 | 0.16 | 0.19 |
| Earnings Per Share Diluted | 0.22 | 0.24 | 0.24 | 0.17 | 0.16 | 0.19 |
| Weighted Average Shares Outstanding | 1.5 Billion | 1.49 Billion | 1.49 Billion | 1.54 Billion | 1.57 Billion | 1.58 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.5 Billion | 1.5 Billion | 1.5 Billion | 1.54 Billion | 1.57 Billion | 1.58 Billion |
| Gross Margin | 0.56 | 0.60 | 0.58 | 0.53 | 0.55 | 0.63 |
| EBIT Margin | 0.43 | 0.37 | 0.37 | 0.36 | 0.36 | 0.42 |
| Profit Margin | 0.28 | 0.28 | 0.31 | 0.26 | 0.27 | 0.32 |
| EBITDA | 498.93 Million | 505.18 Million | 433.88 Million | 395.71 Million | 341.58 Million | 430.55 Million |
| Earnings Before Tax Margin | 0.37 | 0.32 | 0.33 | 0.31 | 0.31 | 0.36 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 501.22 Million | 1.15 Billion | 649.92 Million | 654.2 Million | 1.27 Billion | 623.47 Million |
| Cost of Revenue | 228.78 Million | 509.62 Million | 293.87 Million | 275.87 Million | 511 Million | 235.12 Million |
| Gross Profit | 272.43 Million | 641.51 Million | 356.04 Million | 378.32 Million | 766.67 Million | 388.35 Million |
| Operating Expenses | 201.01 Million | 210.13 Million | 38.96 Million | 176.18 Million | 347.75 Million | 171.56 Million |
| Selling, General and Administrative Expenses | 132.07 Million | - | 128.17 Million | 131.66 Million | - | 133.12 Million |
| Research and Development Expenses | 60.04 Million | - | 30.76 Million | 49.51 Million | - | 29.96 Million |
| Other Expenses | - | 936 Thousand | - | - | 445 Thousand | - |
| Cost and Expenses | 429.8 Million | 719.76 Million | 332.84 Million | 452.06 Million | 858.75 Million | 406.69 Million |
| Operating Income | 84.86 Million | 275.98 Million | 191.12 Million | 194.91 Million | 410.02 Million | 224.18 Million |
| Interest Expense | - | 989 Thousand | - | - | 371 Thousand | - |
| Income Tax Expense | 18.34 Million | 91.39 Million | 73.04 Million | 28.79 Million | 82.55 Million | 53.76 Million |
| Earnings before Tax | 86.84 Million | 414.05 Million | 327.21 Million | 212.81 Million | 438.4 Million | 225.59 Million |
| Net Income | 70.05 Million | 326 Million | 255.94 Million | 186.39 Million | 358.05 Million | 171.66 Million |
| Earnings Per Share Basic | 0.05 | - | 0.17 | 0.12 | - | 0.11 |
| Earnings Per Share Diluted | 0.05 | - | 0.17 | 0.12 | - | 0.11 |
| Weighted Average Shares Outstanding | 1.5 Billion | 1.49 Billion | 1.5 Billion | 1.5 Billion | 1.49 Billion | 1.5 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.5 Billion | 1.5 Billion | 1.5 Billion | 1.5 Billion | 1.5 Billion | 1.5 Billion |
| Gross Margin | 0.54 | 0.56 | 0.55 | 0.58 | 0.60 | 0.62 |
| EBIT Margin | 0.20 | - | 0.39 | 0.33 | - | 0.42 |
| Profit Margin | 0.14 | 0.28 | 0.39 | 0.28 | 0.28 | 0.28 |
| EBITDA | 102.49 Million | - | 251.93 Million | 216.67 Million | - | 263.38 Million |
| Earnings Before Tax Margin | 0.17 | 0.24 | 0.29 | 0.30 | 0.32 | 0.36 |
TILT
SKSUY
EOG
ROS
600160
9555